[1] |
WHO. World malaria report 2023[R]. Geneva: World Health Organization, 2023: 21, 78, 80.
|
[2] |
Noedl H, Se Y, Schaecher K, et al. Evidence of artemisinin-resistant malaria in western Cambodia[J]. N Engl J Med, 2008, 359(24): 2619-2620.
|
[3] |
Balikagala B, Fukuda N, Ikeda M, et al. Evidence of artemisinin-resistant malaria in Africa[J]. N Engl J Med, 2021, 385(13): 1163-1171.
|
[4] |
Hemingway J, Ranson H. Insecticide resistance in insect vectors of human disease[J]. Annu Rev Entomol, 2000, 45: 371-391.
pmid: 10761582
|
[5] |
Zhu GD, Cao J. Regular assessment is an effective approach to maintaining the capacity of prevention of re-establishment from imported malaria in China[J]. Chin J Schisto Control, 2023, 9(2): 113-115, 120. (in Chinese)
|
|
(朱国鼎, 曹俊. 朝督暮责: 定期开展评估是保持防止疟疾输入再传播能力的有效手段[J]. 中国血吸虫病防治杂志, 2023, 9(2): 113-115, 120.)
|
[6] |
Zhu GD, Gao Q, Cao J. Challenges and countermeasures in prevention of re-establishment of imported malaria in China[J]. Chin J Schisto Control, 2021, 33(1): 7-9, 21. (in Chinese)
|
|
(朱国鼎, 高琪, 曹俊. 中国防止疟疾输入再传播面临的挑战和应对策略[J]. 中国血吸虫病防治杂志, 2021, 33(1): 7-9, 21.)
|
[7] |
Xu WY. Development and application of the world’s first malaria subunit vaccine RTS, S/AS01[J]. Chin J Schisto Control, 2021, 7(6): 557-559. (in Chinese)
|
|
(徐文岳. 全球首款疟疾疫苗RTS, S/AS01的研发和应用[J]. 中国血吸虫病防治杂志, 2021, 7(6): 557-559.)
|
[8] |
Stewart MJ, Vanderberg JP. Malaria sporozoites leave behind trails of circumsporozoite protein during gliding motility[J]. J Protozool, 1988, 35(3): 389-393.
|
[9] |
Mota MM, Pradel G, Vanderberg JP, et al. Migration of Plasmodium sporozoites through cells before infection[J]. Science, 2001, 291(5501): 141-144.
doi: 10.1126/science.291.5501.141
pmid: 11141568
|
[10] |
Phillips MA, Burrows JN, Manyando C, et al. Malaria[J]. Nat Rev Dis Primers, 2017, 3: 17050.
doi: 10.1038/nrdp.2017.50
pmid: 28770814
|
[11] |
Amino R, Giovannini D, Thiberge S, et al. Host cell traversal is important for progression of the malaria parasite through the dermis to the liver[J]. Cell Host Microbe, 2008, 3(2): 88-96.
doi: 10.1016/j.chom.2007.12.007
pmid: 18312843
|
[12] |
Amino R, Thiberge S, Blazquez S, et al. Imaging malaria sporozoites in the dermis of the mammalian host[J]. Nat Protoc, 2007, 2(7): 1705-1712.
pmid: 17641635
|
[13] |
Amino R, Thiberge S, Martin B, et al. Quantitative imaging of Plasmodium transmission from mosquito to mammal[J]. Nat Med, 2006, 12(2): 220-224.
|
[14] |
Gueirard P, Tavares J, Thiberge S, et al. Development of the malaria parasite in the skin of the mammalian host[J]. Proc Natl Acad Sci USA, 2010, 107(43): 18640-18645.
doi: 10.1073/pnas.1009346107
pmid: 20921402
|
[15] |
Voza T, Miller JL, Kappe SH, et al. Extrahepatic exoerythrocytic forms of rodent malaria parasites at the site of inoculation: clearance after immunization, susceptibility to primaquine, and contribution to blood-stage infection[J]. Infect Immun, 2012, 80(6): 2158-2164.
doi: 10.1128/IAI.00246-12
pmid: 22431651
|
[16] |
Risco-Castillo V, Topçu S, Marinach C, et al. Malaria sporozoites traverse host cells within transient vacuoles[J]. Cell Host Microbe, 2015, 18(5): 593-603.
pmid: 26607162
|
[17] |
Pradel G, Frevert U. Malaria sporozoites actively enter and pass through rat Kupffer cells prior to hepatocyte invasion[J]. Hepatology, 2001, 33(5): 1154-1165.
pmid: 11343244
|
[18] |
Mota MM, Hafalla JC, Rodriguez A. Migration through host cells activates Plasmodium sporozoites for infection[J]. Nat Med, 2002, 8(11): 1318-1322.
|
[19] |
Carrolo M, Giordano S, Cabrita-Santos L, et al. Hepatocyte growth factor and its receptor are required for malaria infection[J]. Nat Med, 2003, 9(11): 1363-1369.
pmid: 14556002
|
[20] |
Frevert U, Engelmann S, Zougbédé S, et al. Intravital observation of Plasmodium berghei sporozoite infection of the liver[J]. PLoS Biol, 2005, 3(6): e192.
|
[21] |
Pradel G, Garapaty S, Frevert U. Proteoglycans mediate malaria sporozoite targeting to the liver[J]. Mol Microbiol, 2002, 45(3): 637-651.
pmid: 12139612
|
[22] |
Sturm A, Graewe S, Franke-Fayard B, et al. Alteration of the parasite plasma membrane and the parasitophorous vacuole membrane during exo-erythrocytic development of malaria parasites[J]. Protist, 2009, 160(1): 51-63.
doi: 10.1016/j.protis.2008.08.002
pmid: 19026596
|
[23] |
Rodrigues CD, Hannus M, Prudêncio M, et al. Host scavenger receptor SR-BI plays a dual role in the establishment of malaria parasite liver infection[J]. Cell Host Microbe, 2008, 4(3): 271-282.
doi: 10.1016/j.chom.2008.07.012
pmid: 18779053
|
[24] |
Yalaoui S, Zougbédé S, Charrin S, et al. Hepatocyte permissiveness to Plasmodium infection is conveyed by a short and structurally conserved region of the CD81 large extracellular domain[J]. PLoS Pathog, 2008, 4(2): e1000010.
|
[25] |
Silvie O, Greco C, Franetich JF, et al. Expression of human CD81 differently affects host cell susceptibility to malaria sporozoites depending on the Plasmodium species[J]. Cell Microbiol, 2006, 8(7): 1134-1146.
|
[26] |
Kiyuka PK, Meri S, Khattab A. Complement in malaria: Immune evasion strategies and role in protective immunity[J]. FEBS Lett, 2020, 594(16): 2502-2517.
doi: 10.1002/1873-3468.13772
pmid: 32181490
|
[27] |
Simon N, Lasonder E, Scheuermayer M, et al. Malaria parasites co-opt human factor H to prevent complement-mediated lysis in the mosquito midgut[J]. Cell Host Microbe, 2013, 13(1): 29-41.
doi: 10.1016/j.chom.2012.11.013
pmid: 23332154
|
[28] |
Kennedy AT, Schmidt CQ, Thompson JK, et al. Recruitment of factor H as a novel complement evasion strategy for blood-stage Plasmodium falciparum infection[J]. J Immunol, 2016, 196(3): 1239-1248.
|
[29] |
Kennedy AT, Wijeyewickrema LC, Huglo A, et al. Recruitment of human C1 esterase inhibitor controls complement activation on blood stage Plasmodium falciparum merozoites[J]. J Immunol, 2017, 198(12): 4728-4737.
|
[30] |
Kurtovic L, Behet MC, Feng GQ, et al. Human antibodies activate complement against Plasmodium falciparum sporozoites, and are associated with protection against malaria in children[J]. BMC Med, 2018, 16(1): 61.
doi: 10.1186/s12916-018-1054-2
pmid: 29706136
|
[31] |
Boyle MJ, Reiling L, Feng GQ, et al. Human antibodies fix complement to inhibit Plasmodium falciparum invasion of erythrocytes and are associated with protection against malaria[J]. Immunity, 2015, 42(3): 580-590.
|
[32] |
Reiling L, Boyle MJ, White MT, et al. Targets of complement-fixing antibodies in protective immunity against malaria in children[J]. Nat Commun, 2019, 10(1): 610.
doi: 10.1038/s41467-019-08528-z
pmid: 30723225
|
[33] |
Behet MC, Kurtovic L, van Gemert GJ, et al. The complement system contributes to functional antibody-mediated responses induced by immunization with Plasmodium falciparum malaria sporozoites[J]. Infect Immun, 2018, 86(7): e00920-e00917.
|
[34] |
Arbore G, Kemper C, Kolev M. Intracellular complement—the complosome—in immune cell regulation[J]. Mol Immunol, 2017, 89: 2-9.
|
[35] |
Kolev M le Friec G, Kemper C. Complement: tapping into new sites and effector systems[J]. Nat Rev Immunol, 2014, 14(12): 811-820.
|
[36] |
Liszewski MK, Kolev M le Friec G, et al. Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation[J]. Immunity, 2013, 39(6): 1143-1157.
doi: 10.1016/j.immuni.2013.10.018
pmid: 24315997
|
[37] |
Tam JC, Bidgood SR, McEwan WA, et al. Intracellular sensing of complement C3 activates cell autonomous immunity[J]. Science, 2014, 345(6201): 1256070.
|
[38] |
Khan ZM, Vanderberg JP. Role of host cellular response in differential susceptibility of nonimmunized BALB/c mice to Plasmodium berghei and Plasmodium yoelii sporozoites[J]. Infect Immun, 1991, 59(8): 2529-2534.
doi: 10.1128/iai.59.8.2529-2534.1991
pmid: 1855974
|
[39] |
Silvie O, Rubinstein E, Franetich JF, et al. Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity[J]. Nat Med, 2003, 9(1): 93-96.
|
[40] |
Lalli PN, Strainic MG, Yang M, et al. Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis[J]. Blood, 2008, 112(5): 1759-1766.
doi: 10.1182/blood-2008-04-151068
pmid: 18567839
|
[41] |
Zenklusen I, Jongo S, Abdulla S, et al. Immunization of malaria-preexposed volunteers with PfSPZ vaccine elicits long-lived IgM invasion-inhibitory and complement-fixing antibodies[J]. J Infect Dis, 2018, 217(10): 1569-1578.
doi: 10.1093/infdis/jiy080
pmid: 29438525
|
[42] |
Kawamoto Y, Winger LA, Hong K, et al. Plasmodium berghei: Sporozoites are sensitive to human serum but not susceptible host serum[J]. Exp Parasitol, 1992, 75(3): 361-368.
pmid: 1426138
|
[43] |
Huber-Lang M, Sarma JV, Zetoune FS, et al. Generation of C5a in the absence of C3: a new complement activation pathway[J]. Nat Med, 2006, 12(6): 682-687.
doi: 10.1038/nm1419
pmid: 16715088
|
[44] |
Ramos TN, Darley MM, Weckbach S, et al. The C5 convertase is not required for activation of the terminal complement pathway in murine experimental cerebral malaria[J]. J Biol Chem, 2012, 287(29): 24734-24738.
doi: 10.1074/jbc.C112.378364
pmid: 22689574
|
[45] |
Ernest M, Rosa TFA, Pala ZR, et al. Plasmodium falciparum gametes and sporozoites hijack plasmin and factor H to evade host complement killing[J]. Microbiol Spectr, 2023, 11(3): e0449322.
|
[46] |
Schmidt CQ, Kennedy AT, Tham WH. More than just immune evasion: hijacking complement by Plasmodium falciparum[J]. Mol Immunol, 2015, 67(1): 71-84.
|
[47] |
Atkinson JP, Glew RH, Neva FA, et al. Serum complement and immunity in experimental simian malaria. Ⅱ. Preferential activation of early components and failure of depletion of late components to inhibit protective immunity[J]. J Infect Dis, 131(1): 26-33.
|
[48] |
Ramos TN, Bullard DC, Barnum SR. Deletion of the complement phagocytic receptors CR3 and CR4 does not alter susceptibility to experimental cerebral malaria[J]. Parasite Immunol, 2012, 34(11): 547-550.
doi: 10.1111/pim.12002
pmid: 22882618
|